# Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes

> **NCT06427889** · PHASE4 · RECRUITING · sponsor: **Malmö University** · enrollment: 98 (estimated)

## Conditions studied

- Diabetes Mellitus
- Skin and Connective Tissue Diseases

## Interventions

- **DRUG:** Canoderm
- **DRUG:** Oviderm
- **DRUG:** Decubal

## Key facts

- **NCT ID:** NCT06427889
- **Lead sponsor:** Malmö University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-04
- **Primary completion:** 2025-11-07
- **Final completion:** 2026-08-07
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06427889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06427889, "Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06427889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
